{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:33:37Z","timestamp":1787168017256,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11064-025-04460-5","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T05:54:00Z","timestamp":1749707640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dantrolene Protects Hippocampal Neurons Against Amyloid-\u03b2\u2081\u208b\u2084\u2082-Induced Calcium Dysregulation and Cell Death"],"prefix":"10.1007","volume":"50","author":[{"given":"Nataliia M.","family":"Rozumna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita V.","family":"Hanzha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyacheslav M.","family":"Shkryl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Lukyanetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"issue":"1","key":"4460_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2174\/156652406775574514","volume":"6","author":"O Ghribi","year":"2006","unstructured":"Ghribi O (2006) The role of the Endoplasmic reticulum in the accumulation of beta-amyloid peptide in alzheimer\u2019s disease. Curr Mol Med 6(1):119\u2013133. https:\/\/doi.org\/10.2174\/156652406775574514","journal-title":"Curr Mol Med"},{"issue":"1","key":"4460_CR2","first-page":"11","volume":"10","author":"N Soejima","year":"2013","unstructured":"Soejima N, Ohyagi Y, Nakamura N, Himeno E, Iinuma KM, Sakae N et al (2013) Intracellular accumulation of toxic turn amyloid-\u03b2 is associated with Endoplasmic reticulum stress in alzheimer\u2019s disease. Curr Alzheimer Res 10(1):11\u201320","journal-title":"Curr Alzheimer Res"},{"issue":"47","key":"4460_CR3","doi-asserted-by":"publisher","first-page":"16465","DOI":"10.1021\/bi9816195","volume":"37","author":"W Xia","year":"1998","unstructured":"Xia W, Zhang J, Ostaszewski BL, Kimberly WT, Seubert P, Koo EH et al (1998) Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in Endoplasmic reticulum and golgi. Biochemistry 37(47):16465\u201316471. https:\/\/doi.org\/10.1021\/bi9816195","journal-title":"Biochemistry"},{"issue":"4","key":"4460_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.bbrc.2019.10.016","volume":"520","author":"I Bezprozvanny","year":"2019","unstructured":"Bezprozvanny I (2019) Calcium hypothesis of neurodegeneration - An update. Biochem Biophys Res Commun 520(4):667\u2013669. https:\/\/doi.org\/10.1016\/j.bbrc.2019.10.016","journal-title":"Biochem Biophys Res Commun"},{"key":"4460_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ceca.2017.06.008","volume":"70","author":"E Pchitskaya","year":"2018","unstructured":"Pchitskaya E, Popugaeva E, Bezprozvanny I (2018) Calcium signaling and molecular mechanisms underlying neurodegenerative diseases. Cell Calcium 70:87\u201394. https:\/\/doi.org\/10.1016\/j.ceca.2017.06.008","journal-title":"Cell Calcium"},{"issue":"4","key":"4460_CR6","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.bbrc.2016.09.053","volume":"483","author":"E Popugaeva","year":"2017","unstructured":"Popugaeva E, Pchitskaya E, Bezprozvanny I (2017) Dysregulation of neuronal calcium homeostasis in alzheimer\u2019s disease - A therapeutic opportunity? Biochem Biophys Res Commun 483(4):998\u20131004. https:\/\/doi.org\/10.1016\/j.bbrc.2016.09.053","journal-title":"Biochem Biophys Res Commun"},{"key":"4460_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1750-1326-9-21","volume":"9","author":"D Del Prete","year":"2014","unstructured":"Del Prete D, Checler F, Chami M (2014) Ryanodine receptors: physiological function and deregulation in alzheimer disease. Mol Neurodegener 9:21. https:\/\/doi.org\/10.1186\/1750-1326-9-21","journal-title":"Mol Neurodegener"},{"issue":"11","key":"4460_CR8","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nrn960","volume":"3","author":"FM LaFerla","year":"2002","unstructured":"LaFerla FM (2002) Calcium dyshomeostasis and intracellular signalling in alzheimer\u2019s disease. Nat Rev Neurosci 3(11):862\u2013872. https:\/\/doi.org\/10.1038\/nrn960","journal-title":"Nat Rev Neurosci"},{"issue":"4\u20135","key":"4460_CR9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/s0143-4160(03)00128-3","volume":"34","author":"MP Mattson","year":"2003","unstructured":"Mattson MP, Chan SL (2003) Neuronal and glial calcium signaling in alzheimer\u2019s disease. Cell Calcium 34(4\u20135):385\u2013397. https:\/\/doi.org\/10.1016\/s0143-4160(03)00128-3","journal-title":"Cell Calcium"},{"issue":"5","key":"4460_CR10","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1097\/aln.0000000000003224","volume":"132","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liang G, Liang S, Mund R, Shi Y, Wei H (2020) Dantrolene ameliorates impaired neurogenesis and synaptogenesis in induced pluripotent stem cell lines derived from patients with alzheimer\u2019s disease. Anesthesiology 132(5):1062\u20131079. https:\/\/doi.org\/10.1097\/aln.0000000000003224","journal-title":"Anesthesiology"},{"issue":"4","key":"4460_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2174\/1567205017666200522204722","volume":"17","author":"MB Abou","year":"2020","unstructured":"Abou MB, Sun L, Wei H (2020) Approaches to optimizing Dantrolene neuroprotection for the treatment of alzheimer\u2019s disease. Curr Alzheimer Res 17(4):324\u2013328. https:\/\/doi.org\/10.2174\/1567205017666200522204722","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"4460_CR12","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s12551-018-0433-4","volume":"10","author":"DR Laver","year":"2018","unstructured":"Laver DR (2018) Regulation of the RyR channel gating by Ca(2+) and Mg(2). Biophys Rev 10(4):1087\u20131095. https:\/\/doi.org\/10.1007\/s12551-018-0433-4","journal-title":"Biophys Rev"},{"issue":"38","key":"4460_CR13","doi-asserted-by":"publisher","first-page":"31624","DOI":"10.1074\/jbc.R112.349068","volume":"287","author":"F Van Petegem","year":"2012","unstructured":"Van Petegem F (2012) Ryanodine receptors: structure and function. J Biol Chem 287(38):31624\u201331632. https:\/\/doi.org\/10.1074\/jbc.R112.349068","journal-title":"J Biol Chem"},{"key":"4460_CR14","doi-asserted-by":"publisher","unstructured":"Bruno AM, Huang JY, Bennett DA, Marr RA, Hastings ML, Stutzmann GE (2012) Altered ryanodine receptor expression in mild cognitive impairment and alzheimer\u2019s disease. Neurobiol Aging. 33(5):1001.e1-6. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.03.011","DOI":"10.1016\/j.neurobiolaging.2011.03.011"},{"key":"4460_CR15","doi-asserted-by":"publisher","unstructured":"Shkryl VM (2024) Endoplasmic reticulum calcium signaling in hippocampal neurons. Biomolecules 14(12). https:\/\/doi.org\/10.3390\/biom14121617","DOI":"10.3390\/biom14121617"},{"issue":"3","key":"4460_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4161\/chan.27471","volume":"8","author":"J Liu","year":"2014","unstructured":"Liu J, Supnet C, Sun S, Zhang H, Good L, Popugaeva E et al (2014) The role of Ryanodine receptor type 3 in a mouse model of alzheimer disease. Channels (Austin) 8(3):230\u2013242. https:\/\/doi.org\/10.4161\/chan.27471","journal-title":"Channels (Austin)"},{"issue":"6","key":"4460_CR17","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/jnr.20135","volume":"76","author":"E Ferreiro","year":"2004","unstructured":"Ferreiro E, Oliveira CR, Pereira C (2004) Involvement of Endoplasmic reticulum Ca2\u2009+\u2009release through Ryanodine and inositol 1,4,5-triphosphate receptors in the neurotoxic effects induced by the amyloid-beta peptide. J Neurosci Res 76(6):872\u2013880. https:\/\/doi.org\/10.1002\/jnr.20135","journal-title":"J Neurosci Res"},{"issue":"4","key":"4460_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2174\/1567205017666200225102941","volume":"17","author":"M Chami","year":"2020","unstructured":"Chami M, Checler F (2020) Targeting Post-Translational remodeling of Ryanodine receptor: A new track for alzheimer\u2019s disease therapy?? Curr Alzheimer Res 17(4):313\u2013323. https:\/\/doi.org\/10.2174\/1567205017666200225102941","journal-title":"Curr Alzheimer Res"},{"key":"4460_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fnmol.2017.00115","volume":"10","author":"CD SanMart\u00edn","year":"2017","unstructured":"SanMart\u00edn CD, Veloso P, Adasme T, Lobos P, Bruna B, Galaz J et al (2017) RyR2-Mediated Ca(2+) release and mitochondrial ROS generation partake in the synaptic dysfunction caused by amyloid \u03b2 peptide oligomers. Front Mol Neurosci 10:115. https:\/\/doi.org\/10.3389\/fnmol.2017.00115","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"4460_CR20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1471-4159.1991.tb02031.x","volume":"56","author":"A Frandsen","year":"1991","unstructured":"Frandsen A, Schousboe A (1991) Dantrolene prevents glutamate cytotoxicity and Ca2\u2009+\u2009release from intracellular stores in cultured cerebral cortical neurons. J Neurochem 56(3):1075\u20131078. https:\/\/doi.org\/10.1111\/j.1471-4159.1991.tb02031.x","journal-title":"J Neurochem"},{"issue":"6","key":"4460_CR21","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1213\/ANE.0b013e3181f7181c","volume":"111","author":"S Inan","year":"2010","unstructured":"Inan S, Wei H (2010) The cytoprotective effects of dantrolene: a Ryanodine receptor antagonist. Anesth Analg 111(6):1400\u20131410. https:\/\/doi.org\/10.1213\/ANE.0b013e3181f7181c","journal-title":"Anesth Analg"},{"issue":"9","key":"4460_CR22","first-page":"555","volume":"54","author":"M Keshavarz","year":"2016","unstructured":"Keshavarz M, Fotouhi M, Rasti A, Dantrolene (2016) A selective Ryanodine receptor antagonist, protects against Pentylenetetrazole-Induced seizure in mice. Acta Med Iran 54(9):555\u2013561","journal-title":"Acta Med Iran"},{"issue":"23","key":"4460_CR23","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1093\/hmg\/ddw322","volume":"25","author":"B Liou","year":"2016","unstructured":"Liou B, Peng Y, Li R, Inskeep V, Zhang W, Quinn B et al (2016) Modulating Ryanodine receptors with Dantrolene attenuates neuronopathic phenotype in gaucher disease mice. Hum Mol Genet 25(23):5126\u20135141. https:\/\/doi.org\/10.1093\/hmg\/ddw322","journal-title":"Hum Mol Genet"},{"key":"4460_CR24","unstructured":"Ratto D, Joyner RW (2025) Dantrolene. StatPearls. Treasure Island (FL): StatPearls publishing copyright \u00a9 2025. StatPearls Publishing LLC."},{"issue":"1","key":"4460_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4097\/kja.d.18.00139","volume":"72","author":"HJ Kim","year":"2019","unstructured":"Kim HJ, Koh WU, Choi JM, Ro YJ, Yang HS (2019) Malignant hyperthermia and Dantrolene sodium. Korean J Anesthesiol 72(1):78\u201379. https:\/\/doi.org\/10.4097\/kja.d.18.00139","journal-title":"Korean J Anesthesiol"},{"issue":"4","key":"4460_CR26","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","volume":"59","author":"T Krause","year":"2004","unstructured":"Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F (2004) Dantrolene\u2013a review of its pharmacology, therapeutic use and new developments. Anaesthesia 59(4):364\u2013373. https:\/\/doi.org\/10.1111\/j.1365-2044.2004.03658.x","journal-title":"Anaesthesia"},{"key":"4460_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1750-1326-6-81","volume":"6","author":"X Chen","year":"2011","unstructured":"Chen X, Wu J, Lvovskaya S, Herndon E, Supnet C, Bezprozvanny I (2011) Dantrolene is neuroprotective in huntington\u2019s disease Transgenic mouse model. Mol Neurodegener 6:81. https:\/\/doi.org\/10.1186\/1750-1326-6-81","journal-title":"Mol Neurodegener"},{"issue":"8","key":"4460_CR28","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s10571-020-00936-w","volume":"41","author":"L Sun","year":"2021","unstructured":"Sun L, Wei H (2021) Ryanodine receptors: A potential treatment target in various neurodegenerative disease. Cell Mol Neurobiol 41(8):1613\u20131624. https:\/\/doi.org\/10.1007\/s10571-020-00936-w","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"4460_CR29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.neulet.2012.04.008","volume":"516","author":"J Peng","year":"2012","unstructured":"Peng J, Liang G, Inan S, Wu Z, Joseph DJ, Meng Q et al (2012) Dantrolene ameliorates cognitive decline and neuropathology in alzheimer triple Transgenic mice. Neurosci Lett 516(2):274\u2013279. https:\/\/doi.org\/10.1016\/j.neulet.2012.04.008","journal-title":"Neurosci Lett"},{"issue":"4","key":"4460_CR30","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3233\/jad-200227","volume":"76","author":"Y Shi","year":"2020","unstructured":"Shi Y, Zhang L, Gao X, Zhang J, Ben Abou M, Liang G et al (2020) Intranasal Dantrolene as a Disease-Modifying drug in alzheimer 5XFAD mice. J Alzheimers Dis 76(4):1375\u20131389. https:\/\/doi.org\/10.3233\/jad-200227","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"4460_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jatmed.2024.04.002","volume":"3","author":"W Zhang","year":"2024","unstructured":"Zhang W, Zhao X, Bhuiyan P, Liu H, Wei H (2024) Neuroprotective effects of Dantrolene in neurodegenerative disease: role of Inhibition of pathological inflammation. J Anesth Transl Med 3(2):27\u201335. https:\/\/doi.org\/10.1016\/j.jatmed.2024.04.002","journal-title":"J Anesth Transl Med"},{"issue":"1","key":"4460_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/wad.0000000000000076","volume":"29","author":"L Liang","year":"2015","unstructured":"Liang L, Wei H (2015) Dantrolene, a treatment for alzheimer disease? Alzheimer Dis Assoc Disord 29(1):1\u20135. https:\/\/doi.org\/10.1097\/wad.0000000000000076","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"9","key":"4460_CR33","doi-asserted-by":"publisher","first-page":"668","DOI":"10.2174\/1871527317666180619162649","volume":"18","author":"Y Shi","year":"2019","unstructured":"Shi Y, Wang Y, Wei H (2019) Dantrolene: from malignant hyperthermia to alzheimer\u2019s disease. CNS Neurol Disord Drug Targets 18(9):668\u2013676. https:\/\/doi.org\/10.2174\/1871527317666180619162649","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"4460_CR34","doi-asserted-by":"publisher","first-page":"1269664","DOI":"10.3389\/fnins.2023.1269664","volume":"17","author":"NM Rozumna","year":"2023","unstructured":"Rozumna NM, Hanzha VV, Lukyanetz EA (2023) Memantine protects the cultured rat hippocampal neurons treated by NMDA and amyloid \u03b21\u201342. Front Neurosci 17:1269664. https:\/\/doi.org\/10.3389\/fnins.2023.1269664","journal-title":"Front Neurosci"},{"issue":"2","key":"4460_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15407\/FZ67.02.003","volume":"67","author":"VM Shkryl","year":"2021","unstructured":"Shkryl VM, Ganzha VV, Lukyanetz EA (2021) Effect of memantine on calcium signaling in hippocampal neurons cultured with \u03b2-amyloid. Fiziologichnyi Zhurnal 67(2):1\u20138. https:\/\/doi.org\/10.15407\/FZ67.02.003","journal-title":"Fiziologichnyi Zhurnal"},{"issue":"5","key":"4460_CR36","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s11062-021-09891-8","volume":"52","author":"NM Rozumna","year":"2020","unstructured":"Rozumna NM, Shkryl VM, Ganzha VV, Lukyanetz EA (2020) Effects of modeling of hypercalcemia and \u03b2-Amyloid on cultured hippocampal neurons of rats. Neurophysiology 52(5):348\u2013357. https:\/\/doi.org\/10.1007\/s11062-021-09891-8","journal-title":"Neurophysiology"},{"issue":"1","key":"4460_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bbamem.2003.10.003","volume":"1618","author":"EA Lukyanetz","year":"2003","unstructured":"Lukyanetz EA, Shkryl VM, Kravchuk OV, Kostyuk PG (2003) Action of hypoxia on different types of calcium channels in hippocampal neurons. Biochim Biophys Acta 1618(1):33\u201338. https:\/\/doi.org\/10.1016\/j.bbamem.2003.10.003","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"4460_CR38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/s0006-8993(03)02951-2","volume":"980","author":"EA Lukyanetz","year":"2003","unstructured":"Lukyanetz EA, Shkryl VM, Kravchuk OV, Kostyuk PG (2003) Effect of hypoxia on calcium channels depends on extracellular calcium in CA1 hippocampal neurons. Brain Res 980(1):128\u2013134. https:\/\/doi.org\/10.1016\/s0006-8993(03)02951-2","journal-title":"Brain Res"},{"issue":"6","key":"4460_CR39","doi-asserted-by":"publisher","first-page":"e04180","DOI":"10.1016\/j.heliyon.2020.e04180","volume":"6","author":"VM Shkryl","year":"2020","unstructured":"Shkryl VM (2020) Error correction due to background Subtraction in ratiometric calcium measurements with CCD camera. Heliyon 6(6):e04180. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04180","journal-title":"Heliyon"},{"key":"4460_CR40","doi-asserted-by":"publisher","first-page":"1054950","DOI":"10.3389\/fncel.2022.1054950","volume":"16","author":"VM Shkryl","year":"2022","unstructured":"Shkryl VM (2022) The spatio-temporal properties of calcium transients in hippocampal pyramidal neurons in vitro. Front Cell Neurosci 16:1054950. https:\/\/doi.org\/10.3389\/fncel.2022.1054950","journal-title":"Front Cell Neurosci"},{"key":"4460_CR41","doi-asserted-by":"publisher","first-page":"1132092","DOI":"10.3389\/fncel.2023.1132092","volume":"17","author":"VA Yavorsky","year":"2023","unstructured":"Yavorsky VA, Rozumna NM, Lukyanetz EA (2023) Influence of amyloid beta on impulse spiking of isolated hippocampal neurons. Front Cell Neurosci 17:1132092. https:\/\/doi.org\/10.3389\/fncel.2023.1132092","journal-title":"Front Cell Neurosci"},{"key":"4460_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1113\/jphysiol.1980.sp013079","volume":"298","author":"K Kuba","year":"1980","unstructured":"Kuba K (1980) Release of calcium ions linked to the activation of potassium conductance in a caffeine-treated sympathetic neurone. J Physiol 298:251\u2013269. https:\/\/doi.org\/10.1113\/jphysiol.1980.sp013079","journal-title":"J Physiol"},{"issue":"9a","key":"4460_CR43","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1111\/j.1582-4934.2009.00861.x","volume":"13","author":"KN Green","year":"2009","unstructured":"Green KN (2009) Calcium in the initiation, progression and as an effector of alzheimer\u2019s disease pathology. J Cell Mol Med 13(9a):2787\u20132799. https:\/\/doi.org\/10.1111\/j.1582-4934.2009.00861.x","journal-title":"J Cell Mol Med"},{"issue":"12","key":"4460_CR44","doi-asserted-by":"publisher","first-page":"108169","DOI":"10.1016\/j.celrep.2020.108169","volume":"32","author":"J Yao","year":"2020","unstructured":"Yao J, Sun B, Institoris A, Zhan X, Guo W, Song Z et al (2020) Limiting RyR2 open time prevents alzheimer\u2019s Disease-Related neuronal hyperactivity and memory loss but not \u03b2-Amyloid accumulation. Cell Rep 32(12):108169. https:\/\/doi.org\/10.1016\/j.celrep.2020.108169","journal-title":"Cell Rep"},{"issue":"4","key":"4460_CR45","doi-asserted-by":"publisher","first-page":"H953","DOI":"10.1152\/ajpheart.00936.2011","volume":"302","author":"JT Maxwell","year":"2012","unstructured":"Maxwell JT, Domeier TL, Blatter LA (2012) Dantrolene prevents arrhythmogenic Ca2\u2009+\u2009release in heart failure. Am J Physiol Heart Circ Physiol 302(4):H953\u2013H963. https:\/\/doi.org\/10.1152\/ajpheart.00936.2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4460_CR46","doi-asserted-by":"publisher","unstructured":"Schrank S, McDaid J, Briggs CA, Mustaly-Kalimi S, Brinks D, Houcek A et al (2020) Human-induced neurons from presenilin 1 mutant patients model aspects of alzheimer\u2019s disease pathology. Int J Mol Sci 21(3). https:\/\/doi.org\/10.3390\/ijms21031030","DOI":"10.3390\/ijms21031030"},{"key":"4460_CR47","unstructured":"Abou MB, Sun L, Wei H Approaches to optimizing dantrolene neuroprotection for the treatment of alzheimer\u2019s disease. (1875\u20135828 (Electronic))."}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04460-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-025-04460-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04460-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T12:44:30Z","timestamp":1750682670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-025-04460-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["4460"],"URL":"https:\/\/doi.org\/10.1007\/s11064-025-04460-5","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"198"}}